Companies Cryptocurrencies
Syneos Health Inc
Syneos Health Inc
Exchange: Nasdaq Global Select
IPO Date: 07/11/2014
CEO: Mr. Alistair Macdonald
Diagnostics & Research Healthcare 🔗
  • SYNH
  • 70.67
  • 7248974848
    market cap
  • 0.7099991
If you bought

shares of Syneos Health Inc (SYNH) on
You would have made
Old Price $12 Current Price $12

Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. The company is headquartered in Morrisville, North Carolina and currently employs 24,000 full-time employees. The firm focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The firm operates through two segments: Clinical Development Services and Phase I Services. The firm’s Clinical Development Services segment offers a range of clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.

Address: 1030 Sync Street Morrisville NORTH CAROLINA 27560

Stay updated.